Corrigendum to “Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries” [Regul. Pept. 129 (2005) 183–189]

a National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (Building 10, Rm 8C-208), 10 Center Drive, MSC 1752 Bethesda, MD 20892, USA b Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA c Department of Translational Medicine & Technology, GlaxoSmithKline, ACCI, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2GG, UK d Department of Physiology, University of Extremadura, Caceres, Spain